Femur FractureFLiPNCT03868280
The FLiP Study, a Pilot Cluster Randomized Trial
A study testing Antegrade femoral nailing Supine Position and Antegrade Femoral Nailing Lateral Position in people with Femur Fracture, run by Hamilton Health Sciences Corporation at 3 sites in 2 countries.
Trial summary
The primary objective of this pilot trial is to assess the feasibility of a definitive trial to determine the effect of lateral patient positioning versus supine positioning with fracture table use for reamed antegrade intramedullary fixation of femur fractures. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Femur Fracture
- What is being tested?
- Antegrade femoral nailing Supine Position and Antegrade Femoral Nailing Lateral Position
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 3 sitesin 2 countries
- Study dates
- 16 Oct 2020to Jun 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adult aged 18 years or older
- Mid shaft (Diaphyseal) femur fracture appropriate for antegrade fixation
- Surgery performed by participating surgeon or delegate
- Provision of informed consent
- Enrolled within 3 weeks of femoral shaft fixation
Who cannot join
- 1. Ipsilateral tibial fracture 2. Bilateral femur fracture 3. Ipsilateral femoral neck fracture 4. Ipsilateral acetabular fracture 5. Periprosthetic fracture 6. Pathologic fracture 7. Previous external fixation of femoral shaft fracture 8. Inability to be positioned in lateral decubitus because of a concomitant injury 9. Pregnancy (due to decubitus positioning) 10. Incarceration 11. Expected injury survival of less than 6 months 12. Terminal illness with expected survival of less than 6 months (expected follow up of study) 13. Inability to provide informed consent (e.g. cognitive disability, language barrier, significant delirium or dementia) 14. Currently involved in study that does not permit co-enrolment 15. Likely problems, in the judgment of study personnel, with maintaining follow-up with the patient
Trial locations and contacts
3 sites in 2 countries.
Daniel Axelrod, MD contact
3 sites in 2 countries
Canada2 sites, 2 recruiting
- Recruiting
McMaster University
Hamilton, Ontario
Gina Del Fabbro, BPH, 2898080709, delfabbg@mcmaster.ca
Daniel Axelrod, MD, 647 528 9234, daniel.axelrod@medportal.ca
- Recruiting
Ottawa Civic Hospital
Ottawa, Ontario
Melanie Dodd-Moher, 613-737-8899, medodd@ohri.ca
Bradley Meulenkamp, MD, bmeulenkamp@toh.ca
Spain1 site, 1 recruiting
- Recruiting
Vall d'Hebron University Hospital
Barcelona
Yaiza Garcia Sanchez, yaiza.garcia@vhir.org
Ernesto Guerra-Farfan, ernestoguerraf@gmail.com
About this study
Official title: Fracture Table vs. Lateral Positioning for Intramedullary Fixation of Femur Fractures (The FLiP Study): A Pilot Cluster Randomized Crossover Trial
The primary objective of this pilot trial is to assess the feasibility of a definitive trial to determine the effect of lateral patient positioning versus supine positioning with fracture table use for reamed antegrade intramedullary fixation of femur fractures.
Read the detailed description
Femoral shaft fractures typically occur alongside other complex, high-energy injuries in the poly-traumatized patient. Femur fractures can cause extensive bleeding and surrounding muscle injury, and have a high global burden; occurring at a rate between 14 and 42.5 /100,000 person years, with approximately 1 in 10 road traffic accidents worldwide resulting in a femoral shaft fracture requiring surgery. Additionally, there is significant disparity in the burden of diaphyseal femur fractures, with 91% occurring in lower middle-class income countries, and the majority affecting younger males.
To help mitigate the effects of ongoing pain, blood-loss, worsening inflammation from unstable fracture ends, femoral shaft fractures require urgent management using either an early total-care or damage-control orthopaedics approach. Associated injuries, markers of resuscitation, and overall patient stability guide operative decision making and the timing of surgical intervention. Definitive internal fixation using reamed, locked intramedullary nailing (IMN) has become the standard of care in an adequately resuscitated patient, as it provides fracture stability while facilitating nursing care and patient mobilization. Multiple femoral IMN techniques exist; however, most femoral shaft fractures can be treated with an antegrade nail using either supine (fracture table) or lateral (free-leg drape) positioning.
Femoral Malrotation is a Common and Significant Complication
Despite the adoption of femoral IMN, patient-reported function following femur fracture fixation varies widely. Incorrect positioning of the fracture fragments by more than 15° relative to the native limb rotation (femoral malrotation) is associated with poor functional recovery, low health-related quality of life, gait abnormalities, difficulty with stairs, and delayed return to pre-injury activity. Significant femoral malrotation (>15°) occurs in up to 55% of patients following femoral shaft fracture IMN, as measured by post-operative computer tomography (CT) scans. Numerous intraoperative assessments have been used to judge rotation, including cortical diameter, lesser trochanter profile and others; though none are easily reproducible or reliable. The preferred technique by surgeons is the lesser trochanter profile, but this method requires a true anteroposterior view of the pelvis, which can be challenging to obtain with the fracture table in place.
A Lack of Consensus On Operative Table and Patient Positioning While the orthopaedic surgery community agrees that femoral shaft fractures should be treated with IMN, there is a lack of agreement on whether the patient should be placed in the supine position on fracture table (SFT) or in the lateral position on a standard radiolucent operating table (LRT). Our research team recently conducted a survey of the Canadian Orthopaedic Association membership and found a clear divide on patient positioning, with 56% of respondents using supine position on fracture table and 44% using a form of lateral positioning.
A recent comprehensive review identified only three studies on this specific topic. The best existing evidence of the previous literature comes from a prospective randomized trial led by Stephen et al. The authors described that supine positioning without use of fracture table yielded better post-operative rotation than patients treated with a fracture table. However, this study did not assess the utility of lateral positioning, which is more commonly used in isolated femoral shaft fractures. Moreover, the study was unable to associate malrotation with patient important outcomes or gait abnormalities. This clearly leaves much uncertainty surrounding optimal patient positioning during the definitive treatment of these critical injuries.
Proponents of positioning femoral shaft fracture patients using SFT argue that the fracture table provides a constant traction force to stabilize the fractured limb and allows for better intraoperative imaging. This arguably allows surgeons to reduce operative time and minimize the need for surgical assistants. However, possible downsides of this technique include the need for more invasive surgical adjuncts if there is ongoing difficulty with fracture reduction. Furthermore, constant and prolonged traction poses known risks to neurovascular structures associated with the central post, and may overpower feedback from the natural resting tone of the surrounding thigh musculature, possibly leading to a higher incidence of fixation in a malrotated position. Additionally, fracture tables are expensive and require additional setup in the operating room prior to the procedure.
Orthopedic surgeons who prefer the LRT believe it offers improved access to the start point for IMN as well as to the rest of the femur for manipulation, resulting in a better reduction of the fractured limb. With the entire limb free of traction, the thigh sits in a relatively adducted position at rest and the soft tissues tend to fall away from the operative field. The fracture fragments can be readily accessed and freely manipulated, with muscles returning to their resting tension as alignment is restored. It is believed that this leads to leads to improved limb alignment and less malrotation. Furthermore, there may be benefits to the overall patient, many of whom have other severe injuries that may also be impacted by intraoperative positioning. A recent cohort study, which was adjusted for associated injuries, found that patients treated using the LRT had shorter ICU stays and reduced number of days on a ventilator, indicating that there may be a protective effect from a respiratory standpoint. Additionally, the standard operating room table is readily available, less expense, and does not require additional setup prior to the procedure. However, there are concerns that lateral positioning may lead to longer operative times as additional positioning aids and reduction maneuvers may be required. Specifically, patients receiving delayed fixation may pose a challenge due to increased muscle shortening and tone that may be difficult to overcome with manual traction alone.
Limited previous studies align with biomechanical principles, and suggest that lateral positioning holds potential to reduce the incidence of femoral malrotation and avoid complications associated with the use of a fracture table; leading to improved patient function. Addressing malrotation by using the LRT may represent a simple and reproducible intervention that may improve quality of life for the patient.
NEED FOR A TRIAL Currently, the choice between the two techniques is dependent on surgeon preference, with very limited evidence to guide decision making. A large definitive trial is needed to answer this question and allow orthopaedic surgeons to make an evidence-based decision on how to treat patients with femoral shaft fractures, while reducing the incidence of malrotation and improving patient outcomes. Prior to embarking on a large definitive cluster randomized crossover trial (CRXO), a pilot study is needed to demonstrate feasibility. A pilot study would assess areas of uncertainty that may impact feasibility to perform the definitive trial, including achieving adequate recruitment, adherence to protocol, and minimal contamination.
- Conditions
- Femur Fracture
- Being tested
- Antegrade femoral nailing Supine Position, Antegrade Femoral Nailing Lateral Position
- Medical subject headings
- Femoral Fractures
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Antegrade femoral nailing Supine PositionProcedure or surgery
Antegrade femoral nailing in Supine Position using a Fracture Table
Antegrade Femoral Nailing Lateral PositionProcedure or surgery
Antegrade femoral nailing in Lateral Position using a Free drape
| Study group | Role | What they receive |
|---|---|---|
| Supine Positioning, Fracture Table | Active comparator | During the supine fracture table phase, patients will be positioned supine on a fracture table. The operative leg will be placed in a boot, attached to the traction limb. The non-operative leg will either be scissored away from the operating area in a traction boot (without traction placed) or placed in a stirrup at 90 degrees of hip flexion in hemi-lithotomy. A central post will be used to prevent patient movement during application of traction, and all bony prominences will be padded. Fluoroscopy will be obtained through standard practices intraoperative to document assessment of rotation. Receives: Procedure: Antegrade femoral nailing Supine Position |
| Lateral Positioning, Free drape | Active comparator | During the lateral positioning phase, patients will be placed in lateral position after anaesthetic has been provided. A beanbag will be placed below the patient, and the patient will be safely turned to a lateral position. The beanbag will be inflated, the leg will be prepped, and a free drape will be applied. No traction will be used. Alternatively, some participating sites may use stulberg positioners rather than an inflatable beanbag, based on hospital preference. This positioning mirrors the positioning utilized for the direct lateral, posterior or posterolateral approach to a total hip arthroplasty or hemiarthroplasty Receives: Procedure: Antegrade Femoral Nailing Lateral Position |
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility to conduct definitive Clinical Trial
Our primary outcome for the pilot trial is feasibility, which includes the following:
- Recruitment (number of participants recruited across all sites over study period, goal of approximately 100 participants)
- Cluster crossover randomization protocol adherence
- Complete primary outcome collection (CT scans) on all enrolled patients.
- Participant retention and follow-up data
- Accuracy of 15 degrees as a cut off for malrotation
Measured: Six Months
Secondary outcomes (9)
Postoperative femur alignment
Immediate (within 6 weeks of surgery) post-operative bilateral computer tomography (CT scan) of the operated patients' lower extremity will be obtained as per standard of care. Postoperative bilateral CT scans for femoral shaft fractures represents the standard of care across academic centres(13). A physician familiar with musculoskeletal imaging, who is blinded to treatment allocation, will evaluate every CT for each participant. The best available literature defines clinically significant malrotation as more than 15 degrees difference from the contralateral limb in either internal or external rotation (
Measured: Within 6 weeks of injury
Health Related Quality of Life
Health-related quality of life will be assessed with the EQ-5D. The EQ-5D (27) questionnaire will be completed by participants at the time of consent and will ask about their pre-injury health status, as well as health status at the six weeks, three and six months follow up visits. The EQ-5D score represents patient reported health-related quality of life in five domains. The EQ-5D may be administered in person, over the telephone, standard mail, or electronically.
Measured: up to 6 months
Modified Harris Hip Score
The modified Harris Hip Score is a limb specific functional score, which has been validated for use in other orthopedic populations, including those with total joint arthroplasty and hip fractures. The questionnaire will be completed by participants at each follow up appoints. The mHHS may be administered in person, electronically or by telephone.
Measured: up to 6 months
Operative Time, Fluoroscopy Time
Operative time will be defined as the time from induction of anaesthetic and ending once the patient has procedural wounds closed, documented through operative room records. Fluoroscopy time is defined as the total time that fluoroscopy is used and is recorded on the C-Arm used for intraoperative imaging. • The pain is in the study extremity
- The pain began after surgery
- The pain has persisted for at least three months after surgery
- The pain is not better explained by an infection, malignancy, a pre-existing pain condition or any other alternative cause (as judged by the treating surgeon)
- The severity of pain must be at least 4 on an 11-point NRS for average pain in the past week
Measured: At time of Surgery
Need for Open Reduction
Need for open reduction is defined as any secondary incision at the fracture site >5 cm. This incision facilitates open reduction and is viewed as a surrogate measure of difficulty achieving the appropriate reduction using closed manipulation.
Measured: At time of Surgery
Use of Reduction Adjuncts
Use of additional reduction adjuncts is defined as use of less invasive reduction aids (e.g. reduction clamps, joystick pins, F tool, and femoral distractor) not requiring a secondary incision (>5cm) at the fracture site
Measured: At time of Surgery
Operative Table Complications
Standard operative table and fracture table complications include all potential neurological injuries (e.g. pudendal, peroneal and femoral nerve palsies, etc.) and skin injuries (e.g. skin blisters, ulceration, and skin tears, etc.) derived from use of the traction boot apparatus. These will also be documented in the medical record as per standard of care. Complications will be adjudicated by a blinded member of the study team, familiar with both the injury and nature of the operation.
Measured: At time of Surgery, Up to 6 months
Length of Hospital, ICU Stay
Length of hospital stay will be defined as days from admission until the day of discharge to either home, rehabilitation care, or long-term care support. Days in ICU will be recorded according to medical records.
Measured: At initial admission
Days of Ventilator Support
Days of ventilator support will be defined as discrete days spent receiving any form of positive pressure ventilation, including BiPAP while extubated.
Measured: At initial admission
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Mar 2019
- Study start16 Oct 2020
- Primary completionJun 2022 (estimated)
- Study completionJun 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Femur FractureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Pilot cluster randomized crossover trial design
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hamilton Health Sciences Corporation
- Sponsor type
- University, hospital or other
- Collaborators
- Canadian Institutes of Health Research (CIHR), Hamilton Academic Health Sciences Organization, Canadian Orthopaedic Trauma Society
- Responsible party
- Sponsor
- Investigators
- Herman Johal, MD, Principal investigator, McMaster UniversitySheila Sprague, PhD, Principal investigator, McMaster UniversityDaniel Axelrod, MD, Principal investigator, McMaster University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03868280
- Sponsor's protocol ID
- CTO 2108
- Acronym
- FLiP
- Status last verified
- Jul 2021
- First submitted
- 5 Feb 2019
- Last updated
- 28 Jul 2021
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Deidentified participant data will be available upon reasonable request to the Principal Investigators at the end of the study.
Publications
FLiP Investigators; Axelrod DE, Sprague S, Guerra-Farfan E, Garcia-Sanchez Y, Meulenkamp B, Dodd-Moher M, Bzovsky S, Shibu C, Del Fabbro G, Gallant JL, Mammen T, Johal H. Fracture table vs. lateral positioning for intramedullary fixation of femur fractures (The FLiP Trial): the feasibility of a cluster randomized crossover trial. Pilot Feasibility Stud. 2026 Mar 13;12(1):51. doi: 10.1186/s40814-026-01789-8.
PubMed 41821082
Study at a glance
From the registry record, last updated by the sponsor on 28 Jul 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Fracture Table vs. Lateral Positioning for Intramedullary Fixation of Femur Fractures (The FLiP Study): A Pilot Cluster Randomized Crossover Trial
- ClinicalTrials.gov ID
- NCT03868280
- Acronym / sponsor ID
- FLiP / CTO 2108
- Conditions
- Femur Fracture
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Hamilton Health Sciences CorporationUniversity, hospital or other
- Collaborators
- Canadian Institutes of Health Research (CIHR), Hamilton Academic Health Sciences Organization, Canadian Orthopaedic Trauma Society
- Study start
- 16 Oct 2020 (actual)
- Primary completion
- Jun 2022 (estimated)
- Study completion
- Jun 2023 (estimated)
- First posted
- 11 Mar 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary objective of this pilot trial is to assess the feasibility of a definitive trial to determine the effect of lateral patient positioning versus supine positioning with fracture table use for reamed antegrade intramedullary fixation of femur fractures.
Detailed description
Femoral shaft fractures typically occur alongside other complex, high-energy injuries in the poly-traumatized patient. Femur fractures can cause extensive bleeding and surrounding muscle injury, and have a high global burden; occurring at a rate between 14 and 42.5 /100,000 person years, with approximately 1 in 10 road traffic accidents worldwide resulting in a femoral shaft fracture requiring surgery. Additionally, there is significant disparity in the burden of diaphyseal femur fractures, with 91% occurring in lower middle-class income countries, and the majority affecting younger males.
To help mitigate the effects of ongoing pain, blood-loss, worsening inflammation from unstable fracture ends, femoral shaft fractures require urgent management using either an early total-care or damage-control orthopaedics approach. Associated injuries, markers of resuscitation, and overall patient stability guide operative decision making and the timing of surgical intervention. Definitive internal fixation using reamed, locked intramedullary nailing (IMN) has become the standard of care in an adequately resuscitated patient, as it provides fracture stability while facilitating nursing care and patient mobilization. Multiple femoral IMN techniques exist; however, most femoral shaft fractures can be treated with an antegrade nail using either supine (fracture table) or lateral (free-leg drape) positioning.
Femoral Malrotation is a Common and Significant Complication
Despite the adoption of femoral IMN, patient-reported function following femur fracture fixation varies widely. Incorrect positioning of the fracture fragments by more than 15° relative to the native limb rotation (femoral malrotation) is associated with poor functional recovery, low health-related quality of life, gait abnormalities, difficulty with stairs, and delayed return to pre-injury activity. Significant femoral malrotation (>15°) occurs in up to 55% of patients following femoral shaft fracture IMN, as measured by post-operative computer tomography (CT) scans. Numerous intraoperative assessments have been used to judge rotation, including cortical diameter, lesser trochanter profile and others; though none are easily reproducible or reliable. The preferred technique by surgeons is the lesser trochanter profile, but this method requires a true anteroposterior view of the pelvis, which can be challenging to obtain with the fracture table in place.
A Lack of Consensus On Operative Table and Patient Positioning While the orthopaedic surgery community agrees that femoral shaft fractures should be treated with IMN, there is a lack of agreement on whether the patient should be placed in the supine position on fracture table (SFT) or in the lateral position on a standard radiolucent operating table (LRT). Our research team recently conducted a survey of the Canadian Orthopaedic Association membership and found a clear divide on patient positioning, with 56% of respondents using supine position on fracture table and 44% using a form of lateral positioning.
A recent comprehensive review identified only three studies on this specific topic. The best existing evidence of the previous literature comes from a prospective randomized trial led by Stephen et al. The authors described that supine positioning without use of fracture table yielded better post-operative rotation than patients treated with a fracture table. However, this study did not assess the utility of lateral positioning, which is more commonly used in isolated femoral shaft fractures. Moreover, the study was unable to associate malrotation with patient important outcomes or gait abnormalities. This clearly leaves much uncertainty surrounding optimal patient positioning during the definitive treatment of these critical injuries.
Proponents of positioning femoral shaft fracture patients using SFT argue that the fracture table provides a constant traction force to stabilize the fractured limb and allows for better intraoperative imaging. This arguably allows surgeons to reduce operative time and minimize the need for surgical assistants. However, possible downsides of this technique include the need for more invasive surgical adjuncts if there is ongoing difficulty with fracture reduction. Furthermore, constant and prolonged traction poses known risks to neurovascular structures associated with the central post, and may overpower feedback from the natural resting tone of the surrounding thigh musculature, possibly leading to a higher incidence of fixation in a malrotated position. Additionally, fracture tables are expensive and require additional setup in the operating room prior to the procedure.
Orthopedic surgeons who prefer the LRT believe it offers improved access to the start point for IMN as well as to the rest of the femur for manipulation, resulting in a better reduction of the fractured limb. With the entire limb free of traction, the thigh sits in a relatively adducted position at rest and the soft tissues tend to fall away from the operative field. The fracture fragments can be readily accessed and freely manipulated, with muscles returning to their resting tension as alignment is restored. It is believed that this leads to leads to improved limb alignment and less malrotation. Furthermore, there may be benefits to the overall patient, many of whom have other severe injuries that may also be impacted by intraoperative positioning. A recent cohort study, which was adjusted for associated injuries, found that patients treated using the LRT had shorter ICU stays and reduced number of days on a ventilator, indicating that there may be a protective effect from a respiratory standpoint. Additionally, the standard operating room table is readily available, less expense, and does not require additional setup prior to the procedure. However, there are concerns that lateral positioning may lead to longer operative times as additional positioning aids and reduction maneuvers may be required. Specifically, patients receiving delayed fixation may pose a challenge due to increased muscle shortening and tone that may be difficult to overcome with manual traction alone.
Limited previous studies align with biomechanical principles, and suggest that lateral positioning holds potential to reduce the incidence of femoral malrotation and avoid complications associated with the use of a fracture table; leading to improved patient function. Addressing malrotation by using the LRT may represent a simple and reproducible intervention that may improve quality of life for the patient.
NEED FOR A TRIAL Currently, the choice between the two techniques is dependent on surgeon preference, with very limited evidence to guide decision making. A large definitive trial is needed to answer this question and allow orthopaedic surgeons to make an evidence-based decision on how to treat patients with femoral shaft fractures, while reducing the incidence of malrotation and improving patient outcomes. Prior to embarking on a large definitive cluster randomized crossover trial (CRXO), a pilot study is needed to demonstrate feasibility. A pilot study would assess areas of uncertainty that may impact feasibility to perform the definitive trial, including achieving adequate recruitment, adherence to protocol, and minimal contamination.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- Pilot cluster randomized crossover trial design
| Arm | Type | Receives |
|---|---|---|
| Supine Positioning, Fracture Table | Active comparator | Procedure: Antegrade femoral nailing Supine PositionDuring the supine fracture table phase, patients will be positioned supine on a fracture table. The operative leg will be placed in a boot, attached to the traction limb. The non-operative leg will either be scissored away from the operating area in a traction boot (without traction placed) or placed in a stirrup at 90 degrees of hip flexion in hemi-lithotomy. A central post will be used to prevent patient movement during application of traction, and all bony prominences will be padded. Fluoroscopy will be obtained through standard practices intraoperative to document assessment of rotation. |
| Lateral Positioning, Free drape | Active comparator | Procedure: Antegrade Femoral Nailing Lateral PositionDuring the lateral positioning phase, patients will be placed in lateral position after anaesthetic has been provided. A beanbag will be placed below the patient, and the patient will be safely turned to a lateral position. The beanbag will be inflated, the leg will be prepped, and a free drape will be applied. No traction will be used. Alternatively, some participating sites may use stulberg positioners rather than an inflatable beanbag, based on hospital preference. This positioning mirrors the positioning utilized for the direct lateral, posterior or posterolateral approach to a total hip arthroplasty or hemiarthroplasty |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Adult aged 18 years or older
- Mid shaft (Diaphyseal) femur fracture appropriate for antegrade fixation
- Surgery performed by participating surgeon or delegate
- Provision of informed consent
- Enrolled within 3 weeks of femoral shaft fixation
Key exclusion criteria (1 listed)
- 1. Ipsilateral tibial fracture 2. Bilateral femur fracture 3. Ipsilateral femoral neck fracture 4. Ipsilateral acetabular fracture 5. Periprosthetic fracture 6. Pathologic fracture 7. Previous external fixation of femoral shaft fracture 8. Inability to be positioned in lateral decubitus because of a concomitant injury 9. Pregnancy (due to decubitus positioning) 10. Incarceration 11. Expected injury survival of less than 6 months 12. Terminal illness with expected survival of less than 6 months (expected follow up of study) 13. Inability to provide informed consent (e.g. cognitive disability, language barrier, significant delirium or dementia) 14. Currently involved in study that does not permit co-enrolment 15. Likely problems, in the judgment of study personnel, with maintaining follow-up with the patient
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Antegrade femoral nailing Supine PositionAntegrade femoral nailing in Supine Position using a Fracture Table | Procedure or surgery | Supine Positioning, Fracture Table |
| Antegrade Femoral Nailing Lateral PositionAntegrade femoral nailing in Lateral Position using a Free drape | Procedure or surgery | Lateral Positioning, Free drape |
Primary outcome
Feasibility to conduct definitive Clinical Trial
Time frame: Six Months
Our primary outcome for the pilot trial is feasibility, which includes the following: * Recruitment (number of participants recruited across all sites over study period, goal of approximately 100 participants) * Cluster crossover randomization protocol adherence * Complete primary outcome collection (CT scans) on all enrolled patients. * Participant retention and follow-up data * Accuracy of 15 degrees as a cut off for malrotation
9 secondary outcomes
Postoperative femur alignment
Time frame: Within 6 weeks of injury
Health Related Quality of Life
Time frame: up to 6 months
Modified Harris Hip Score
Time frame: up to 6 months
Operative Time, Fluoroscopy Time
Time frame: At time of Surgery
Need for Open Reduction
Time frame: At time of Surgery
Use of Reduction Adjuncts
Time frame: At time of Surgery
Operative Table Complications
Time frame: At time of Surgery, Up to 6 months
Length of Hospital, ICU Stay
Time frame: At initial admission
Days of Ventilator Support
Time frame: At initial admission
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jul 2021.
- Derived from this study: PubMed 41821082FLiP Investigators; Axelrod DE, Sprague S, Guerra-Farfan E, Garcia-Sanchez Y, Meulenkamp B, Dodd-Moher M, Bzovsky S, Shibu C, Del Fabbro G, Gallant JL, Mammen T, Johal H. Fracture table vs. lateral positioning for intramedullary fixation of femur fractures (The FLiP Trial): the feasibility of a cluster randomized crossover trial. Pilot Feasibility Stud. 2026 Mar 13;12(1):51. doi: 10.1186/s40814-026-01789-8.
- Individual participant dataSharing planned: Yes. Deidentified participant data will be available upon reasonable request to the Principal Investigators at the end of the study.
Related trials for Femur Fracture
Not yet recruiting
Lumbar Erector Spinae Plane Block Versus PENG Block for Hip Fracture Surgery
Femur Neck Fracture, Hip Fractures
Active, not recruiting
Lumbar-Sacral Plexus Block vs Fascia Iliaca Block Plus Low-Dose Spinal Anesthesia for Femoral Neck Fracture Surgery
Femoral Neck Fractures, Nerve Block
Not yet recruiting
Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures
Tibial Fracture, Femoral Fracture
RecruitingObservational study
Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures
Fracture; Pelvic, Insufficiency Fractures
Enrolling by invitationObservational study
GRACE II (General Retrospective Analysis of Commercial Experience With AGN1 LOEP)
Osteoporosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Daniel Axelrod, MD contact
Herman Johal, MD principal investigator
McMaster University
Sheila Sprague, PhD principal investigator
McMaster University
Daniel Axelrod, MD principal investigator
McMaster University
3 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Antegrade femoral nailing Supine Position and Antegrade Femoral Nailing Lateral Position in people with Femur Fracture, run by Hamilton Health Sciences Corporation at 3 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 28 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Canada, Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Gina Del Fabbro, BPH (2898080709, delfabbg@mcmaster.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility to conduct definitive Clinical Trial (time frame: Six Months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03868280, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2021.